Resources for Food and Drug Administration (FDA)

FDA calls Novartis promotional magnet 'misleading'

www.forbes.com

Regulators have issued a warning to Novartis over a promotional magnet for its epilepsy drug, saying it does not adequately warn consumers about the medication's risks. The Food and Drug Administration has asked the company to stop using the magnet to promote its drug Trileptal.

The front of the magnet features two claims, with different benefits displayed depending on the angle of the viewer. FDA said information about the drug's risks is printed on the back, where no one sees it if the magnet is stuck to a surface.

View the Resource

Share or bookmarklet this web page at: